6.6273
price down icon0.75%   -0.0427
 
loading
Precedente Chiudi:
$6.67
Aprire:
$6.71
Volume 24 ore:
385.51K
Relative Volume:
0.31
Capitalizzazione di mercato:
$574.42M
Reddito:
-
Utile/perdita netta:
$-168.09M
Rapporto P/E:
-3.0541
EPS:
-2.17
Flusso di cassa netto:
$-138.01M
1 W Prestazione:
+3.76%
1M Prestazione:
+12.78%
6M Prestazione:
-19.37%
1 anno Prestazione:
-68.60%
Intervallo 1D:
Value
$6.475
$6.739
Intervallo di 1 settimana:
Value
$6.255
$6.739
Portata 52W:
Value
$5.41
$21.60

Kura Oncology Inc Stock (KURA) Company Profile

Name
Nome
Kura Oncology Inc
Name
Telefono
(858) 500-8800
Name
Indirizzo
12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO, CA
Name
Dipendente
192
Name
Cinguettio
@kuraoncology
Name
Prossima data di guadagno
2025-02-21
Name
Ultimi documenti SEC
Name
KURA's Discussions on Twitter

Confronta KURA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
KURA
Kura Oncology Inc
6.635 530.70M 0 -168.09M -138.01M -2.17
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
475.91 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.20 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.99 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
573.25 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.03 29.19B 3.81B -644.79M -669.77M -6.24

Kura Oncology Inc Stock (KURA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-06 Downgrade BTIG Research Buy → Neutral
2024-10-24 Iniziato UBS Buy
2024-10-14 Downgrade Stifel Buy → Hold
2023-12-22 Iniziato Mizuho Buy
2023-08-11 Iniziato BofA Securities Buy
2023-07-27 Iniziato Scotiabank Sector Perform
2023-05-17 Iniziato BTIG Research Buy
2023-01-31 Iniziato Stifel Buy
2022-07-12 Iniziato Cantor Fitzgerald Overweight
2022-02-15 Iniziato Jefferies Buy
2021-05-05 Ripresa Credit Suisse Outperform
2021-04-26 Ripresa Credit Suisse Outperform
2020-12-07 Reiterato H.C. Wainwright Buy
2020-12-03 Iniziato Stifel Buy
2020-11-05 Downgrade Piper Sandler Overweight → Neutral
2020-07-07 Iniziato Credit Suisse Outperform
2020-05-05 Iniziato Barclays Overweight
2019-07-18 Iniziato Deutsche Bank Buy
2018-11-09 Iniziato Piper Jaffray Overweight
2018-08-01 Iniziato H.C. Wainwright Buy
2016-10-13 Ripresa Leerink Partners Outperform
2016-01-22 Iniziato JMP Securities Mkt Outperform
2015-12-30 Iniziato Oppenheimer Outperform
2015-12-16 Iniziato Citigroup Buy
Mostra tutto

Kura Oncology Inc Borsa (KURA) Ultime notizie

pulisher
Jul 22, 2025

Kura Oncology Inc. Stock Analysis and ForecastExplosive earnings growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Kura Oncology Inc. stockTriple-digit returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Kura Oncology Inc. stock priceBreakneck growth rates - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Kura Oncology Inc. a good long term investmentConsistently high returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 18, 2025

Kura Oncology, Inc. (NASDAQ:KURA) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Jul 18, 2025
pulisher
Jul 16, 2025

Why Kura Oncology Inc. stock attracts strong analyst attentionFree AI-Driven Trading Strategies - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Menin Inhibitors Market Forecasts Signal Strong Uptake of Menin Inhibitors in Hematologic Oncology Across the 7MM During the Forecast Period (2020-2034) | DelveInsight - Yahoo Finance

Jul 15, 2025
pulisher
Jul 15, 2025

How Kura Oncology Inc. stock performs during market volatilityFree Access to Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Kura Oncology Inc. stock price move sharplyHigh Reward Risk Balanced Trading - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Health Check: How Prudently Does Kura Oncology (NASDAQ:KURA) Use Debt? - simplywall.st

Jul 14, 2025
pulisher
Jul 10, 2025

Wealth Enhancement Advisory Services LLC Takes $139,000 Position in Kura Oncology, Inc. (NASDAQ:KURA) - Defense World

Jul 10, 2025
pulisher
Jul 03, 2025

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jul 03, 2025
pulisher
Jul 03, 2025

Kura Oncology shares rise 3.34% after-hours following inducement grants to new employees. - AInvest

Jul 03, 2025
pulisher
Jul 02, 2025

Kura Oncology's Ziftomenib: A Near-Term FDA Catalyst and a Paradigm Shift for AML Patients - AInvest

Jul 02, 2025
pulisher
Jul 01, 2025

Kura Oncology Partners with Kyowa Kirin for Ziftomenib - TipRanks

Jul 01, 2025
pulisher
Jul 01, 2025

Kura Oncology and Kyowa Kirin enter agreement to co-promote leukemia drug in US - Investing.com

Jul 01, 2025
pulisher
Jul 01, 2025

Kura Oncology and Kyowa Kirin enter agreement to co-promote leukemia drug in US By Investing.com - Investing.com South Africa

Jul 01, 2025
pulisher
Jun 29, 2025

Kura Oncology, Inc.(NasdaqGS: KURA) added to Russell 3000E Value Index - MarketScreener

Jun 29, 2025
pulisher
Jun 27, 2025

Kura Oncology (NASDAQ:KURA) Given Overweight Rating at Cantor Fitzgerald - Defense World

Jun 27, 2025
pulisher
Jun 26, 2025

KURA: Cantor Fitzgerald Reiterates Overweight Rating | KURA Stoc - GuruFocus

Jun 26, 2025
pulisher
Jun 22, 2025

Kura Oncology, Inc. (NASDAQ:KURA) Shares Acquired by Rhumbline Advisers - Defense World

Jun 22, 2025
pulisher
Jun 20, 2025

KURA: Wedbush Reiterates 'Outperform' Rating with $36 Price Target | KURA Stock News - GuruFocus

Jun 20, 2025
pulisher
Jun 18, 2025

Transcript : Kura Oncology, Inc.Special Call - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

Kura Oncology Announces Positive Phase 1a/1b Trial Results - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

Long Term Trading Analysis for (KURA) - news.stocktradersdaily.com

Jun 18, 2025
pulisher
Jun 17, 2025

Kura Oncology rises after new early-stage trial data for leukemia therapy - MSN

Jun 17, 2025
pulisher
Jun 15, 2025

Pallas Capital Advisors LLC Invests $66,000 in Kura Oncology, Inc. (NASDAQ:KURA) - Defense World

Jun 15, 2025
pulisher
Jun 15, 2025

Kura Oncology, Inc. (NASDAQ:KURA) Shares Sold by Harbor Capital Advisors Inc. - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

Kura Oncology’s SWOT analysis: ziftomenib’s potential reshapes AML treatment stock outlook - Investing.com Australia

Jun 14, 2025
pulisher
Jun 13, 2025

Kura Oncology’s SWOT analysis: ziftomenib’s potential reshapes AML treatment stock outlook By Investing.com - Investing.com South Africa

Jun 13, 2025
pulisher
Jun 12, 2025

KURA's Ziftomenib Shows Promising Results in AML Clinical Trial - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology reports positive data for AML treatment ziftomenib By Investing.com - Investing.com South Africa

Jun 12, 2025
pulisher
Jun 12, 2025

Is the Options Market Predicting a Spike in Kura Oncology Stock? - The Globe and Mail

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology (KURA) Shows Promising Results for AML Therapy - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology Says Ziftomenib Study Achieves Complete Remission in Acute Myeloid Leukemia - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology stock rises on leukemia drug data (KURA:NASDAQ) - Seeking Alpha

Jun 12, 2025
pulisher
Jun 12, 2025

Is The Options Market Predicting A Spike In Kura Oncology Stock? - Barchart.com

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology and Kyowa Kirin Report Positive Updated Combinatio - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology’s SWOT analysis: ziftomenib stock potential in AML treatment By Investing.com - Investing.com Canada

Jun 12, 2025

Kura Oncology Inc Azioni (KURA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Kura Oncology Inc Azioni (KURA) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
FORD KATHLEEN
Chief Operating Officer
May 19 '25
Sale
6.28
1,558
9,777
21,367
$22.70
price up icon 4.15%
$35.89
price down icon 0.50%
$101.97
price down icon 0.63%
$27.64
price up icon 4.18%
$113.50
price up icon 1.83%
biotechnology ONC
$295.77
price up icon 0.11%
Capitalizzazione:     |  Volume (24 ore):